HLA Molecular Typing and HLA Antibody Detection / Identification - 4535237

A Tender Notice
by BUSINESS SERVICES ORGANISATION, PROCUREMENT AND LOGISTICS SERVICES ON BEHALF OF THE BELFAST HEALTH AND SOCIAL CARE TRUST

Source
Find a Tender
Type
Contract (Goods)
Duration
5 year
Value
£5M-£5M
Sector
INDUSTRIAL
Published
21 Nov 2022
Delivery
To 12 Jun 2029 (est.)
Deadline
16 Jan 2023 15:00

Concepts

Location

Geochart for 2 buyers and 0 suppliers

2 buyers

Description

HLA Molecular Typing and HLA Antibody Detection / Identification

Lot Division

1 Molecular Typing: Kits, Software and Automated Platform for the HLA Typing of DNA Samples
  • Value: £2M
2 Antibodies Detection (screening): Platform, Reagents, Kits, Controls and Consumables for HLA specific Antibody Detection and Intermediate Testing
  • Value: £2M
3 Antibodies Identification (75 percent): Platform, Reagents, Kits, Controls and Consumables for HLA specific Antibody Identification
  • Value: £831K

HLA Molecular Typing and HLA Antibody Detection / Identification. Additional information: BHSCT guidelines recommend employing a combination of tests for Antibody Identification in order to fully resolve complex antibody profiles. As a result, lots 3 and 4 will share the Antibodies Identification requirement. Lot 3 will receive 75 percent of the estimated workload, while Lot 4 will receive 25 percent.

Award Criteria
price _
4 Antibodies Identification (25 percent): Platform, Reagents, Kits, Controls and Consumables for HLA specific Antibody Identification
  • Value: £277K

HLA Molecular Typing and HLA Antibody Detection / Identification. Additional information: BHSCT guideline recommend employing a combination of tests for Antibody Identification in order to fully resolve complex antibody profiles. As a result, lots 3 and 4 will share the Antibodies Identification requirement. Lot 3 will receive 75 percent of the estimated workload, while Lot 4 will receive 25 percent.

Award Criteria
price _
5 DNA Amplification Platform and Associated Products
  • Value: £125K

HLA Molecular Typing and HLA Antibody Detection / Identification. Additional information: This estimated total value stated in II 2.6) is the highest value in the following range 80000GBP to 125000GBP.

Award Criteria
price _
6 DNA Quantification Platform and Associated Products
  • Value: £67K

HLA Molecular Typing and HLA Antibody Detection / Identification. Additional information: This estimated total value stated in II 2.6) is the highest value in the following range 30000GBP to 67000GBP.

Award Criteria
price _
7 DNA Visualisation Platform and Associated Products
  • Value: £80K

HLA Molecular Typing and HLA Antibody Detection / Identification. Additional information: This estimated total value stated in II 2.6) is the highest value in the following range 35000 GBP to 80000 GBP.

Award Criteria
price _

Renewal Options

It is anticipated that this contract will be for a duration of 5 years. The client may at any time before the completion of the contract period invite the contractor to agree to extend for any period(s) up to and including 24 months commencing from the expiry date of the original contract period.

CPV Codes

  • 38000000 - Laboratory, optical and precision equipments (excl. glasses)
  • 33000000 - Medical equipments, pharmaceuticals and personal care products

Indicators

  • Restrictions apply to the lot award allocation.
  • This is a one-off contract (no recurrence)
  • Options are available.
  • Renewals are not available.

Other Information

** PREVIEW NOTICE, please check Find a Tender for full details. ** In section 1.2 it is stated that this procurement is by a Central Purchasing Body, operated by BSO PaLS on behalf of the Belfast Health and Social Care Trust. The cost of responding to and participating in the procurement process generally will be borne solely by each economic operator participating. Any expenditure, work or effort undertaken prior to a contract award is at the risk of the economic operator participating in this procurement process. Economic operators should note that the Contracting Authority reserves the right to cancel this procurement process at any stage. Any date given in Section IV above is a best estimated at the time of dispatch. The Contracting Authority reserves the right to extend any such date within the scope of the applicable procurement regulations.

Reference

Domains